Understanding the differences between these medications can help you and your healthcare provider decide which one may be right for you, or if it's time to make a move from one to the other
Product Specifications Synonyms: LY3298176, P1206, tirzepatida, tirzepatidum CAS Number: 2023788-19-2 Molecular Formula: CHNO Molecular Weight: 48 g/mol Peptide Sequence: Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys(C20)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH Purity: 95% (verified by HPLC and mass spectrometry) Packaging Format: 100 mg lyophilized powder in a sealed research-grade vial Storage Conditions: Store 28 C (20 C long term)
Users often report noticeable changes in their appetite and eating habits within the first few weeks of treatment
Patients with GERD or Gastroparesis The SNAC absorption enhancer can irritate stomach lining and worsen: Gastroesophageal reflux disease Chronic gastritis Delayed stomach emptying Peptic ulcers Injectable options dont have these issues
With steady support and proper care, energy levels tend to even out over time
This slow increase in dose is also helpful for keeping blood sugar from going too high or too low, which improves glycemic control